Concepedia

Naomi Tamaki

NT

6

Publications

96

Citations

6

H-Index

1995

Active since

Affiliations

Japanese Foundation For Cancer Research(Current)

Zenyaku Kogyo (Japan)

Tokyo University of Technology

Naomi Tamaki is an author at Japanese Foundation For Cancer Research specializing in medicine, pharmacology, and tumor biology.

Top concepts

Publications per year

1995–2018

6

Publications

6

M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted Gastric Cancers

Yoshimi Ohashi, Mutsumi Okamura, Asaka Hirosawa et al. · Cancer Research · 2016 · 33 citations · Full text

Recombinant human lactoferrin-Fc fusion with an improved plasma half-life

Yuki Shiga, Yuta Oshima, Yoshinori Kojima et al. · European Journal of Pharmaceutical Sciences · 2014 · 15 citations

, ,

Antitumor profile of the PI3K inhibitor ZSTK474 in human sarcoma cell lines

Nachi Namatame, Naomi Tamaki, Yuya Yoshizawa et al. · Oncotarget · 2018 · 15 citations · Full text

Basal expression of insulin‐like growth factor 1 receptor determines intrinsic resistance of cancer cells to a phosphatidylinositol 3‐kinase inhibitor ZSTK474

Sho Isoyama, Gensei Kajiwara, Naomi Tamaki et al. · Cancer Science · 2014 · 12 citations · Full text

, , +16

Localization of apoptotic cells in situ of brain tumors.

Takashi Kokunai, Hirofumi Sawa, Naomi Tamaki · PubMed · 1995 · 11 citations

, , +14

Rows per page

1–5 of 6